A novel intraperitoneal therapy for gastric cancer with DFP-10825, a unique RNAi therapeutic targeting thymidylate synthase, in a peritoneally disseminated xenograft model. [electronic resource]
Producer: 20200924Description: 7313-7321 p. digitalISSN:- 2045-7634
- Animals
- Antineoplastic Agents -- administration & dosage
- Cell Line, Tumor
- Humans
- Injections, Intraperitoneal
- Liposomes -- administration & dosage
- Male
- Mice
- Peritoneal Neoplasms -- drug therapy
- RNA, Small Interfering -- administration & dosage
- Stomach Neoplasms -- drug therapy
- Thymidylate Synthase -- antagonists & inhibitors
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.